Principal Financial Group Inc Enanta Pharmaceuticals Inc Transaction History

Principal Financial Group Inc

$172 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	SELL	$20.68 - $39.85 $126,478 - $243,722	-6,116 Reduced 5.03%	115,487 $2.47 Million
Q1 2023 May 09, 2023	SELL	$38.82 - $54.59 $30,861 - $43,399	-795 Reduced 0.65%	121,603 $4.92 Million
Q4 2022 Feb 09, 2023	SELL	$40.77 - $53.73 $208,620 - $274,936	-5,117 Reduced 4.01%	122,398 $5.69 Million
Q3 2022 Nov 09, 2022	SELL	$48.29 - $71.27 $120,531 - $177,889	-2,496 Reduced 1.92%	127,515 $6.61 Million
Q2 2022 Aug 10, 2022	BUY	$38.13 - $76.93 $276,175 - $557,203	7,243 Added 5.9%	130,011 $6.15 Million
Q1 2022 May 09, 2022	BUY	$56.06 - $74.11 $28,422 - $37,573	507 Added 0.41%	122,768 $8.74 Million
Q4 2021 Feb 09, 2022	SELL	$60.19 - $97.37 $265,377 - $429,304	-4,409 Reduced 3.48%	122,261 $9.14 Million
Q3 2021 Nov 09, 2021	SELL	$41.02 - $58.65 $94,017 - $134,425	-2,292 Reduced 1.78%	126,670 $7.2 Million
Q2 2021 Aug 10, 2021	BUY	$43.76 - $53.11 $48,529 - $58,898	1,109 Added 0.87%	128,962 $5.68 Million
Q1 2021 May 10, 2021	BUY	$41.69 - $54.95 $32,226 - $42,476	773 Added 0.61%	127,853 $6.31 Million
Q4 2020 Feb 08, 2021	SELL	$41.16 - $47.47 $193,987 - $223,726	-4,713 Reduced 3.58%	127,080 $5.35 Million
Q3 2020 Nov 06, 2020	BUY	$43.36 - $53.53 $284,441 - $351,156	6,560 Added 5.24%	131,793 $6.03 Million
Q2 2020 Aug 05, 2020	BUY	$46.37 - $57.58 $45,442 - $56,428	980 Added 0.79%	125,233 $6.29 Million
Q1 2020 May 12, 2020	SELL	$40.22 - $62.0 $195,268 - $301,010	-4,855 Reduced 3.76%	124,253 $6.39 Million
Q4 2019 Feb 05, 2020	BUY	$57.95 - $66.61 $194,943 - $224,076	3,364 Added 2.68%	129,108 $7.98 Million
Q3 2019 Nov 13, 2019	SELL	$60.08 - $88.17 $122,443 - $179,690	-2,038 Reduced 1.59%	125,744 $7.56 Million
Q2 2019 Aug 12, 2019	SELL	$81.3 - $97.35 $847,552 - $1.01 Million	-10,425 Reduced 7.54%	127,782 $10.8 Million
Q1 2019 May 10, 2019	BUY	$69.08 - $105.66 $71,705 - $109,675	1,038 Added 0.76%	138,207 $13.2 Million
Q4 2018 Feb 14, 2019	SELL	$65.41 - $84.65 $154,040 - $199,350	-2,355 Reduced 1.69%	137,169 $9.72 Million
Q3 2018 Nov 14, 2018	BUY	$85.46 - $126.37 $1.29 Million - $1.91 Million	15,112 Added 12.15%	139,524 $11.9 Million
Q2 2018 Aug 13, 2018	BUY	$81.85 - $120.51 $891,182 - $1.31 Million	10,888 Added 9.59%	124,412 $0
Q1 2018 May 14, 2018	BUY	$57.91 - $92.15 $206,449 - $328,514	3,565 Added 3.24%	113,524 $9.19 Million
Q4 2017 Feb 13, 2018	BUY	$45.65 - $59.37 $79,202 - $103,006	1,735 Added 1.6%	109,959 $6.45 Million
Q3 2017 Nov 02, 2017	BUY	$37.91 - $46.8 $4.1 Million - $5.06 Million	108,224	108,224 $5.07 Million

Others Institutions Holding ENTA

# of Institutions

110

Shares Held

21.1M

Call Options Held

4.8K

Put Options Held

4.6K

Farallon Capital Management LLC San Francisco, CA

2.11M
Shares

$19.7 Million
0.11% of portfolio
Vanguard Group Inc Valley Forge, PA

1.98M
Shares

$18.5 Million
0.0% of portfolio
Black Rock Inc. New York, NY

1.85M
Shares

$17.3 Million
0.0% of portfolio
Krensavage Asset Management, LLC New York, NY

1.5M
Shares

$14 Million
8.7% of portfolio
Morgan Stanley New York, NY

1.1M
Shares

$10.3 Million
0.0% of portfolio

View Full List

About ENANTA PHARMACEUTICALS INC

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $194M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

More about ENTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account